Vendors embark on new relationship and contracts to grow business and impact care.
Across the country – and in a time of anticipated global PACS growth – several vendors are increasing their market share.
Carestream announced this week that Arcispedale S. Maria Nuova of Italy and Owen Sound Hospital, a member of Grey Bruce Health Services in Canada, have implemented the company’s digital breast tomosynthesis (DBT) module. This module allows providers to display DBT exams and images from other mammography modalities on the Carestream Vue Mammography Workstation.
Agfa Healthcare recently announced Amiri Hospital in Kuwait City, Kuwait, is now covering all radiology areas of the hospital with Agfa’s IMPAX PACS and RIS. This upgrade covers the main radiology department, emergency department, and the MRI and gastroenterology units. There are future plans to extend coverage to the intensive care and critical care units. This expansion also includes 21 diagnostic workstations and 40 RIS stations.
Lexmark International, a digital information connection company, recently acquired PACSGEAR, a leading, global PACS and electronic medical records company. PACSGEAR already serves 50 countries worldwide and roughly half of all U.S. hospitals. With this acquisition, PACSGEAR will report to Lexmark’s Perceptive Software, creating the opportunity for Perceptive Software to offer a vendor-neutral, standards-based clinical content platform for capturing and managing patient imaging information.
New Literature Review Assesses Merits of Cardiac MRI After Survival of Sudden Cardiac Arrest
April 19th 2024While noting inconsistencies with the diagnostic yield of cardiac MRI in patients who survived sudden cardiac arrest, researchers cited unique advantages in characterizing ischemic cardiomyopathy (ICM) and facilitating alternate diagnoses.
Study of Ofatumumab for Multiple Sclerosis Shows 'Profoundly Suppressed MRI Lesion Activity'
April 17th 2024The use of continuous ofatumumab in patients within three years of a relapsing multiple sclerosis diagnosis led to substantial reductions in associated lesions on brain MRI scans, according to research recently presented at the American Academy of Neurology (AAN) conference.